𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignant plasma cell tumors in human immunodeficiency virus-infected patients

✍ Scribed by Jay E. Gold; Lori Schwam; Antonio Castella; Sheldon B. Pike; Richard Opfell; Ralph Zalusky


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
689 KB
Volume
66
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


The development of malignant neoplasms in patients with the acquired immune deficiency syndrome (AIDS) or with a positive human immunodeficiency virus (HIV) antibody test is a well known phenomenon. According to the guidelines from the Centers for Disease Control (Atlanta, GA), the presence of intermediate-grade or high-grade B-cell non-Hodgkin's lymphoma in HIV antibody-positive patients is considered a diagnostic criterion for AIDS. The authors describe two cases of malignant plasma cell tumors in two young HIV-infected patients. In light of this and other reports of plasma cell tumors in patients at risk for AIDS or with a positive HIV antibody test, the finding of another manifestation of B-cell neoplasia in these patients may enlarge the spectrum of AIDS-related tumors.


πŸ“œ SIMILAR VOLUMES


Testicular germ cell tumors in patients
✍ Marcus U. Hentrich; Norbert G. Brack; Peter Schmid; Tobias Schuster; Christoph C πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 813 KB

## BACKGROUND. There has been evidence of a higher incidence of testicular germ cell tumors (GCT) in human immunodeficiency virus (HlV)-seropositive men than in the non HIV-infected male population. Most authors recommend standard therapy for HIV-positive patients with GCT but the immunosuppressive

Hepatitis E virus infection in patients
✍ Mamadou Kaba; HervΓ© Richet; Isabelle Ravaux; Jacques Moreau; Isabelle Poizot-Mar πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 212 KB πŸ‘ 1 views

## Abstract Hepatitis E virus (HEV) is a newly‐identified causative agent of acute and chronic hepatitis in severely immunocompromized patients. The present study sought to assess the prevalences of past, recent, on‐going, and chronic HEV infections in patients infected with human immunodeficiency